In ovarian cancer, activation of the JAK–STAT signaling pathway is associated with neoplastic progression, so one of the treatment strategies for ovarian cancer may be considered the inhibition of the JAK–STAT signaling pathway [64,65,66]. This evidence concerns the gene SOAT1 and ovarian carcinoma.